Home
Vista Pharmaceuticals Ltd Board of Directors
Board of Directors at Vista Pharmaceuticals Ltd
Company Sec. & Compli. Officer
Non-Exec. & Independent Dir.
Chairman & Wholetime Director
Director
Non-Exec. & Independent Dir.
Key Highlights
- Dhananjaya Alli joins the board as Chairman / Executive Director / WTD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Murali Meraga joins the board as Executive Director & MD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pavan Sathvik Gilaka joins the board as E D & Wholetime Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Stanley Prabhakar Reddy joins the board as Non Executive & Non WTD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Mallem Hanumantha Rao joins the board as Non Executive & Non WTD, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Vista Pharmaceuticals Ltd
NSE: VISTAPHARMA
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 21 Nov 2025 | 9 |
| 20 Nov 2025 | 8.62 |
| 19 Nov 2025 | 9.18 |
| 18 Nov 2025 | 7.65 |
| 17 Nov 2025 | 8.39 |
| 14 Nov 2025 | 9.42 |
| 13 Nov 2025 | 9.26 |
| 12 Nov 2025 | 9.54 |
| 11 Nov 2025 | 9.47 |
| 10 Nov 2025 | 9.6 |
Company Fundamentals for Vista Pharmaceuticals Ltd
Market Cap
55 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
1.2
Day’s High
9.35
Day’s Low
8.79
DTE
0.2
ROE
-15.0
52 Week High
13.09
52 Week Low
7.63
ROCE
-13.5
Market Price of Vista Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Vista Pharmaceuticals Ltd News Hub
Vista Pharmaceuticals reports standalone net loss of Rs 0.86 crore in the June 2024 quarter
Net Loss of Vista Pharmaceuticals reported to Rs 0.86 crore in the quarter ended June 2024 as agains
Read more
14 Aug 24
Vista Pharmaceuticals to discuss results
Vista Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2024
Read more
06 Aug 24
Vista Pharmaceuticals to conduct AGM
Vista Pharmaceuticals announced that the 33th Annual General Meeting (AGM) of the company will be he
Read more
10 Sept 24
Vista Pharmaceuticals reports standalone net loss of Rs 0.97 crore in the September 2024 quarter
Net Loss of Vista Pharmaceuticals reported to Rs 0.97 crore in the quarter ended September 2024 as a
Read more
14 Nov 24
